Cargando…
Frequency, Predictors, and Economic Impact of Upward Dose Adjustment of Infliximab in Managed Care Patients With Rheumatoid Arthritis
OBJECTIVES: To examine dosing patterns and costs among rheumatoid arthritis (RA) patients newly treated with infliximab in a large national health care claims database. METHODS: Using data from a proprietary database of pharmacy and medical claims for 75 U.S. health plans, RA patients newly treated...
Autores principales: | Ollendorf, Daniel A., Massarotti, Elena, Birbara, Charles, Burgess, Somali Misra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438098/ https://www.ncbi.nlm.nih.gov/pubmed/15934797 http://dx.doi.org/10.18553/jmcp.2005.11.5.383 |
Ejemplares similares
-
Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results
por: Nozaki, Yuji, et al.
Publicado: (2018) -
Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study
por: Gilbert, Thomas D, et al.
Publicado: (2004) -
Infliximab in the treatment of rheumatoid arthritis
por: Perdriger, A
Publicado: (2009) -
How does infliximab work in rheumatoid arthritis?
por: Maini, Ravinder N, et al.
Publicado: (2002) -
The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis
por: Lindberg, Johan, et al.
Publicado: (2010)